About   Help   FAQ
Lgr6tm2.1(cre/ERT2)Cle - Renal & Urinary System
Recombinase Activity Detail
Allele Information
Allele:
Lgr6tm2.1(cre/ERT2)Cle
leucine-rich repeat-containing G protein-coupled receptor 6; targeted mutation 2.1, Hans Clevers
Driver: Lgr6
Type: Targeted (Inducible, Null/knockout, Recombinase, Reporter)
Inducer: tamoxifen
Synonym: Lgr6-EGFP, Lgr6-EGFP-Ires-CreERT2
Molecular description: An EGFP-IRES-CreERT2 cassette was inserted at the transcriptional start site along with a loxP-flanked neomycin cassette by homologous recombination. The neomycin gene was then removed by cre mediated recombination. EGFP expression is driven by the endogenous promoter. Cre expression is induced by tamoxifen treatment.
Find mice (IMSR): Mouse Strains: 1 strain available       Cell Lines: 0 lines available
Additional Tissues: Lgr6tm2.1(cre/ERT2)Cle activity also observed in:
head, integumental system, mesenchyme, respiratory system, sensory organs
Tissue Information
Renal & Urinary System Other recombinase alleles with activity in Renal & Urinary System tissues:
Images
Drag images to compare to others or to data in the table below. Drag corners to resize images for more detail. Reset Images
J:312349 Fig. 1 J:312349 Fig. 5 J:312349 Fig. 6
Recombinase Activity
Click heading to re-sort table.
Assays Genotypic Background Result Notes  
References
All for this allele: 37 reference(s)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory